Access & Uptake
The Sabin Vaccine Institute works to extend the benefits of immunization to all people by enabling vaccine access and uptake. Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines. Our work includes a number of diseases, including:
One-third of the world’s population is at risk of contracting typhoid, a systemic bacterial infection spread through contaminated food and water that kills more than 128,000 people each year, primarily children in low-income countries. Caused by Salmonella enterica serotype Typhi (S. Typhi), typhoid is an acute illness that is often misdiagnosed because its symptoms – prolonged fever, headache, nausea, constipation, loss of appetite and diarrhea – are so common.
Working together to shape global health solutions is more important than ever. Sabin seeks to extend the benefits of immunization to everyone by bringing together representatives from across the private and public sectors to identify key challenges facing global immunization and help establish best practices and recommendations to overcome them.
Vaccine introduction, policy and financing are complex issues, and countries must achieve ambitious immunization targets with limited available resources. To make informed decisions for the health of their people, decision makers need accurate, up-to-date information to identify vulnerable populations, assess burden of disease, evaluate vaccine efficacy and cost-effectiveness, and measure the efficiency of immunization programs.
Over the last decade, many new vaccines have been developed, but the promise of these vaccines is only fulfilled when they are administered around the world. To deliver health to as many people as possible, countries need accurate, high-quality data to ensure their resources are used effectively.
Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines.
Vaccines are an essential public good that governments provide to their citizens. Vaccine costs are rising, often faster than public immunization budgets are expanding. Many countries currently eligible for financial support from Gavi, the Vaccine Alliance, are graduating or will soon graduate from this support. These countries must therefore depend on domestic sources to maintain or improve their immunization programs.